Brought to you by 
Actavis divests four drugs to Amneal in order to complete Warner Chilcott acquisition
18 Nov 2022
Executive Summary
As part of an agreement to complete its pending merger with Warner Chilcott PLC (WC), Actavis Inc. has divested four drugs to Amneal Pharmaceuticals LLC (generics) for an undisclosed amount of cash.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Generic Drugs
- Specialty Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- Marketing (Licensing)
- Product Purchase
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Actavis divests four drugs to Amneal in order to complete Warner Chilcott acquisition
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice